Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. Filiaci · SciRah

Researcher profile · Semantic Scholar

V. Filiaci

Share profile

V. Filiaci — researcher profile on SciRah

h-index: 28
Works: 53
Citations: 4,434

Most-cited papers

Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.
Marcus E. Randall, V. Filiaci, H. Muss, Nick M. Spirtos +4 more
2006Journal of Clinical Oncology784 citations Open access
Semantic Scholar
Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer
D. Matei, V. Filiaci, M. Randall, D. Mutch +14 more
2019New England Journal of Medicine409 citations Open access
Semantic Scholar
Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209).
D. Miller, V. Filiaci, R. Mannel, D. Cohn +14 more
2020Journal of Clinical Oncology293 citations Open access
Semantic Scholar
Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer.
Marcus E. Randall, V. Filiaci, D. S. McMeekin, V. E. von Gruenigen +15 more
2019Journal of Clinical Oncology291 citations Open access
Semantic Scholar
Late-Breaking Abstract 1: Randomized phase III noninferiority trial of first line chemotherapy for metastatic or recurrent endometrial carcinoma: A Gynecologic Oncology Group study
D. Miller, V. Filiaci, G. Fleming, R. Mannel +6 more
2012231 citations
Semantic Scholar
Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study.
H. Homesley, V. Filiaci, M. Markman, P. Bitterman +4 more
2007Journal of Clinical Oncology230 citations
Semantic Scholar
Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study.
G. Fleming, V. Filiaci, Rex C. Bentley, Thomas J. Herzog +3 more
2004Annals of Oncology201 citations Open access
Semantic Scholar
An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: a Gynecologic Oncology Group study.
T. Grushko, V. Filiaci, A. Mundt, Karin K. Ridderstråle +2 more
2008Gynecologic Oncology176 citations Open access
Semantic Scholar
Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study.
M. Powell, V. Filiaci, P. Rose, R. Mannel +5 more
2010Journal of Clinical Oncology161 citations Open access
Semantic Scholar
The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study.
D. Mcmeekin, V. Filiaci, J. Thigpen, Holly H. Gallion +2 more
2007Gynecologic Oncology159 citations
Semantic Scholar
Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study.
R. Osborne, V. Filiaci, J. Schink, R. Mannel +6 more
2011Journal of Clinical Oncology156 citations Open access
Semantic Scholar
A Phase II Study of Frontline Paclitaxel/Carboplatin/Bevacizumab, Paclitaxel/Carboplatin/Temsirolimus, or Ixabepilone/Carboplatin/Bevacizumab in Advanced/Recurrent Endometrial Cancer
C. Aghajanian, V. Filiaci, D. Dizon, J. Carlson +12 more
2018Gynecologic Oncology135 citations Open access
Semantic Scholar
Temsirolimus with or without Megestrol Acetate and Tamoxifen for Endometrial Cancer: a Gynecologic Oncology Group Study
G. Fleming, V. Filiaci, B. Marzullo, R. Zaino +11 more
2014Gynecologic Oncology123 citations Open access
Semantic Scholar
Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative
J. Bogaerts, M. Sydes, Nicola Keat, Andrea McConnell +42 more
2014European Journal of Cancer123 citations Open access
Semantic Scholar
A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study.
B. Slomovitz, V. Filiaci, J. Walker, Michael Taub +8 more
2022Gynecologic Oncology77 citations Open access
Semantic Scholar
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial
M. Powell, V. Filiaci, M. Hensley, Helen Q. Huang +11 more
2022Journal of Clinical Oncology77 citations Open access
Semantic Scholar
Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: an NRG Oncology study
K. Leslie, V. Filiaci, A. Mallen, Kristina W. Thiel +18 more
2021Gynecologic Oncology76 citations Open access
Semantic Scholar
Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol
W. Creasman, Shamshad Ali, D. Mutch, R. Zaino +14 more
2017Gynecologic Oncology72 citations Open access
Semantic Scholar
TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study
Kristina W. Thiel, E. Devor, V. Filiaci, D. Mutch +12 more
2022Journal of Clinical Oncology71 citations Open access
Semantic Scholar
1A randomized phase III trial of pelvic radiation therapy (PXRT) versus vaginal cuff brachytherapy followed by paclitaxel/carboplatin chemotherapy (VCB/C) in patients with high risk (HR), early stage endometrial cancer (EC): A Gynecologic Oncology Group trial
D. Mcmeekin, V. Filiaci, C. Aghajanian, J. Cho +6 more
201469 citations
Semantic Scholar
Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia
R. Osborne, V. Filiaci, J. Schink, R. Mannel +6 more
2016Obstetrics and Gynecology63 citations Open access
Semantic Scholar
A Phase 3 Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High-Risk, Early-Stage Endometrial Cancer: A Gynecology Oncology Group Study
M. Randall, V. Filiaci, D. Mcmeekin, C. Yashar +14 more
201740 citations
Semantic Scholar
A randomized phase II study of paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus and ixabepilone/carboplatin/bevacizumab as initial therapy for measurable stage III or IVA, stage IVB or recurrent endometrial cancer, GOG-86P.
C. Aghajanian, V. Filiaci, D. Dizon, J. Carlson +10 more
201540 citations
Semantic Scholar
An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275
J. Schink, V. Filiaci, Helen Q. Huang, J. Tidy +9 more
2020Gynecologic Oncology38 citations Open access
Semantic Scholar
Phase II Evaluation of Dalantercept, a Soluble Recombinant Activin Receptor-Like Kinase 1 (ALK1) Receptor Fusion Protein, for the Treatment of Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study 0229N
V. Makker, V. Filiaci, Lee-may Chen, C. Darus +4 more
2015Gynecologic Oncology36 citations Open access
Semantic Scholar
Phase II trial of pulse dactinomycin as salvage therapy for failed low‐risk gestational trophoblastic neoplasia
A. Covens, V. Filiaci, Robert A. Burger, R. Osborne +1 more
2006Cancer34 citations Open access
Semantic Scholar
A randomized phase 3 trial of paclitaxel (P) plus carboplatin (C) versus paclitaxel plus ifosfamide (I) in chemotherapy-naive patients with stage I-IV, persistent or recurrent carcinosarcoma of the uterus or ovary: An NRG Oncology trial.
M. Powell, V. Filiaci, M. Hensley, Helen Q. Huang +12 more
2019Journal of Clinical Oncology32 citations
Semantic Scholar
A randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel vs. carboplatin and paclitaxel for optimally debulked, advanced endometrial carcinoma.
D. Matei, V. Filiaci, Marcus E. Randall, Margaret M. Steinhoff +11 more
201729 citations
Semantic Scholar
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study
A. Myers, V. Filiaci, Yuping Zhang, M. Pearl +10 more
2015Gynecologic Oncology28 citations Open access
Semantic Scholar
GOG 3007, a randomized phase II (RP2) trial of everolimus and letrozole (EL) or hormonal therapy (medroxyprogesterone acetate/tamoxifen, PT) in women with advanced, persistent or recurrent endometrial carcinoma (EC): A GOG Foundation study
B. Slomovitz, V. Filiaci, R. Coleman, J. Walker +3 more
2018Gynecologic Oncology27 citations
Semantic Scholar
Hormone therapy plus temsirolimus for endometrial carcinoma (EC): Gynecologic Oncology Group trial #248.
G. Fleming, V. Filiaci, Parviz Hanjani, J. J. Burke +3 more
2011Journal of Clinical Oncology27 citations
Semantic Scholar
High Stathmin Expression is a Marker for Poor Clinical Outcome in Endometrial Cancer: an NRG Oncology Group/Gynecologic Oncology Group Study
H. Reyes, J. Miecznikowski, J. Gonzalez-Bosquet, E. Devor +14 more
2017Gynecologic Oncology25 citations Open access
Semantic Scholar
Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study.
K. Tewari, V. Filiaci, N. Spirtos, R. Mannel +4 more
2012Gynecologic Oncology21 citations
Semantic Scholar
A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial Cancer and Validation of Biomarkers of Cellular Response
L. Duska, V. Filiaci, J. Walker, L. L. Holman +14 more
2021Clinical Cancer Research20 citations Open access
Semantic Scholar
Disparities in health-related quality of life in women undergoing treatment for advanced ovarian cancer: The role of individual-level and contextual social determinants
Jennifer L. Moss, Jeanne Murphy, V. Filiaci, L. Wenzel +2 more
2018Supportive Care in Cancer18 citations Open access
Semantic Scholar
Synuclein-γ (SNCG) in Uterine Serous Carcinoma Impacts Survival: An NRG Oncology/ Gynecologic Oncology Group study
A. Winder, Kruti P. Maniar, Jian-Jun Wei, Da-Chao Liu +20 more
2016Cancer13 citations Open access
Semantic Scholar
Patient Reported Outcomes for Cisplatin and Radiation Followed by Carboplatin/Paclitaxel versus Carboplatin/Paclitaxel for Locally Advanced Endometrial Carcinoma: An NRG Oncology study
U. Matulonis, Helen Q. Huang, V. Filiaci, M. Randall +12 more
2021Gynecologic Oncology8 citations Open access
Semantic Scholar
Evidence for synthetic lethality between bevacizumab and chemotherapy in advanced, p53 null endometrial cancers
A. Mallen, V. Filiaci, D. Levine, Kristina W. Thiel +12 more
2018Gynecologic Oncology7 citations
Semantic Scholar
Predictive biomarkers of endometrial cancer response: Results from NRG Oncology/Gynecologic Oncology Group study 86P
D. Levine, D. Dizon, J. Carlson, V. Filiaci +13 more
2018Gynecologic Oncology6 citations
Semantic Scholar
Effects of slide storage on detection of molecular markers by IHC and FISH in endometrial cancer tissues from a clinical trial: an NRG Oncology/GOG pilot study
T. Grushko, V. Filiaci, A. Montag, M. Apushkin +10 more
2021Applied immunohistochemistry & molecular morphology (Print)4 citations Open access
Semantic Scholar
2A phase II study to determine the response to second curettage as initial management for persistent “low-risk” non-metastatic gestational trophoblastic neoplasia: A Gynecologic Oncology Group study
R. Osborne, V. Filiaci, R. Mannel, S. Davidson +6 more
20143 citations
Semantic Scholar
Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor-fusion protein, for treatment of recurrent/persistent endometrial cancer: GOG-0229N.
V. Makker, V. Filiaci, Lee-may Chen, C. Darus +4 more
20143 citations
Semantic Scholar
Evaluation of slide storage and detection of molecular markers by immunohistochemistry (IHC) in formalin-fixed, paraffin embedded endometrial cancer tissues from a clinical trial: A GOG study
T. Grushko, V. Filiaci, A. Montag, M. Apushkin +7 more
20142 citations
Semantic Scholar
A phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: A Gynecologic Oncology Group (GOG) study.
M. Powell, V. Filiaci, P. Rose, R. Mannel +5 more
2009Journal of Clinical Oncology2 citations
Semantic Scholar
Abstract PO020: Approval for the proliferative marker Ki-67 as an integrated biomarker for endometrial cancer in NRG study GY011
M. Samuelson, V. Filiaci, K. Carrick, Anand Rajan Kd +4 more
2021Molecular Stratification1 citations
Semantic Scholar
Acknowledgment of Reviewers 2021
Dome, Da Dong, Kristine A. Donovan, Lesly A. Dossett +170 more
2022Microbial Drug Resistance0 citations
Semantic Scholar
Abstract PR006: Correlation of immunohistochemistry with TP53 sequence and clinical outcomes in GOG-086P
Kristina W. Thiel, E. Devor, V. Filiaci, D. Levine +5 more
2021Molecular Stratification0 citations
Semantic Scholar
Disparities in health-related quality of life in women undergoing treatment for ovarian cancer: The role of individual-level and contextual social determinants.
Jennifer L. Moss, Jeanne Murphy, V. Filiaci, L. Wenzel +2 more
20180 citations
Semantic Scholar
Clinical trial designs for rare diseases : Studies developed and discussed by the International Rare Cancers Initiative BOGAERTS
J. Bogaerts, M. Sydes, Nicola Keat, Andrea McConnell +36 more
20170 citations
Semantic Scholar
University of Birmingham Clinical trial designs for rare diseases
J. Bogaerts, M. Sydes, Nicola Keat, A. Ho +30 more
20150 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Tewari×15
Invite
K. Tewari — researcher profile on SciRah
D. Miller×14
Invite
D. Miller — researcher profile on SciRah
M. Powell×13
Invite
M. Powell — researcher profile on SciRah
R. Mannel×12
Invite
R. Mannel — researcher profile on SciRah

×12

Invite

C. Aghajanian — researcher profile on SciRah

Invite

G. Fleming — researcher profile on SciRah

Invite

K. Leslie — researcher profile on SciRah

P. DiSilvestro×8

Invite

P. DiSilvestro — researcher profile on SciRah

Invite

K. Moxley — researcher profile on SciRah

Helen Q. Huang×7

Invite

Helen Q. Huang — researcher profile on SciRah

Invite

M. Pearl — researcher profile on SciRah

Invite

A. Secord — researcher profile on SciRah